Prescriber & Dispensing Licensing
All dermatological prescription therapies facilitated through Tretinoin Australia operate strictly under the Therapeutic Goods Act 1989 (Cth) and are reviewed by registered Australian medical practitioners and dispensed by accredited pharmacists.
Prescribing Practitioners
Australian Telehealth Medical Practitioner Network (Provider Reg: MED000192847).
Registered with the Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia.
Evaluation of patient clinical assessments, evaluation of contraindications (including teratogenic risk during pregnancy), and issuance of personalized dermatological treatment protocols.
Dispensing Pharmacy
Apex Compounding & Pharmacy (Pharmacy Board of Australia Reg: PHA0002148901).
Marcus Vance (B.Pharm MPS, AHPRA Reg: PHA00018942).
Formulated and packed under Good Compounding Practice (GCP) guidelines and Therapeutic Goods Order standards for topical dermal stability.
Therapeutic Goods Act & Schedule 4 Compliance
In Australia, topical all-trans retinoic acid (Tretinoin) and Hydroquinone preparations are classified as Schedule 4 (Prescription Animal and Human Remedy) under the national Poisons Standard. As a consequence:
- No medicine is dispatched without an authorized medical questionnaire review and clinical approval.
- Patient history regarding retinoid sensitivity, eczema, rosacea, and UV exposure is screened prior to regimen formulation.
- A direct clinical contraindication applies to any individual currently pregnant, planning pregnancy, or nursing.
- All packages are securely prepared with batch numbers, active ingredient concentrations, and clinical usage instructions clearly affixed.